News & Updates

CCRM partners with Membio to streamline production of viral vectors for cell and gene therapies

January 9, 2023

Viral vectors are critical components in the manufacturing of cell and gene therapies, but their production is currently a key bottleneck and cost driver. CCRM, a leader in developing and commercializing cell and gene therapies, has partnered with Membio, a Canadian biotechnology company developing a 0.2-10 L benchtop single-use bioreactor system, to streamline production of viral vectors. This will be the first collaboration of the two organizations and will explore combining Membio’s bioreactor system with CCRM’s innovative virus producing cell line...

Read full press release >

The 2023 SOSV Human Health 100

April 3, 2023

SOSV

The second annual SOSV Human Health 100! The list captures SOSV’s 100 most exciting companies in human health as of April 2023.

From SOSV’s standpoint, each company on the Human Health 100 represents a unique window into the very rapid advances taking place in fields as varied as cancer therapeutics, CRISPR platforms, assistive robotics, and remote healthcare, to name a few...

Manufacturing Innovations Taking Root in Canada: Showcasing 15 Dynamic Startups

March 8, 2023

Canada Venture News

Canada has become a hub for innovation and entrepreneurship, and manufacturing startups are no exception. These startups are paving the way for a brighter future in Canada’s industrial landscape.

In this article, Membio is featured as one of the 15 most interesting and innovative manufacturing startups in Canada.

cell and gene therapy insights article t

Thinking ahead: developing biosynthetic blood to anticipate donor drought

January 3, 2023

Cell & Gene Therapy Insights

Advances in scientific research suggest the possibility of a viable biosynthetic blood technology that could radically transform the health outcomes of people around the world. Such a development would enhance a drastically insufficient global supply of red blood cells needed for transfusions, while also mitigating severe risks to donor supply precipitated by future pandemic or environmental catastrophes...

The 2022 SOSV Human Health 100

March 1, 2022

SOSV

More than 200 companies in our 1000+ company portfolio focus on health, and recently we sat down to rank our top 100, based on current as well as expected performance. The result is our first annual SOSV Human Health 100...

Heat Map: 5 Top Cell Therapy Startups

October 13, 2020

StartUS

Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on solutions for the pharma sector. As there is a large number of startups working on a wide variety of solutions, we want to share our insights with you. This time, we are taking a look at 5 promising cell therapy startups...

Opportunities at the Intersection of Biology, Software, and Automation

July 13, 2020

True Ventures

Over the past two decades, we’ve seen hundreds of billions of dollars of market capitalization created by new software and infrastructure companies built at the intersection of mobile, data, and cloud computing. Now, we’re in the middle of an even larger shift at the intersection of biology, software, and automation as old industries are reimagined and entirely new ones are created.

The Biology of Business

June 30, 2020

BIOS

The 21st century will be an era defined by biological innovation. Accompanying this revolution, biology will inspire a fundamental change impacting our understanding of business & how we think about building, growing, and sustaining companies of the future...

Investors

Investment & Partnering

Interested in learning more about the company, investing in Membio's future, or partnering with us? Reach out!